GHK-Cu: A Copper Complex Research Reference

GHK-Cu: A Copper Complex Research Reference

GHK-Cu is unlike almost everything else in a research peptide catalogue. It is not simply a peptide but a metal coordination complex — a tripeptide bound to a copper(II) ion. That distinction is not a technicality: it changes what the material looks like, how it must be analysed, and what a complete specification has to establish. This reference sets out the chemistry.

The scope is coordination chemistry and analytical verification. No use of any kind is described.

Chemical identity

GHK-Cu carries CAS registry number 49557-75-7. Its molecular formula is C14H24N6O4Cu, giving a molecular weight of approximately 403.9 g/mol. The peptide component is Gly-His-Lys — glycyl-L-histidyl-L-lysine, abbreviated GHK — a tripeptide of just three residues.

The arithmetic is worth following, because it establishes the stoichiometry. The GHK tripeptide alone has formula C14H24N6O4 and a molecular weight near 340.4 g/mol. Copper has an atomic weight of approximately 63.5. The complex at 403.9 g/mol therefore contains exactly one copper ion per peptide molecule — a 1:1 complex. A material described as GHK-Cu but reporting a mass near 340 would be the uncomplexed peptide, not the copper complex at all.

How the copper is bound

The GHK sequence is not arbitrary. Its three residues provide a well-matched set of coordinating atoms for a copper(II) ion: the N-terminal amine, the imidazole nitrogen of the histidine side chain, and the deprotonated amide nitrogen of the backbone all participate in binding the metal. Histidine in particular is among the most common metal-coordinating residues in biological chemistry, and its presence at the central position of a tripeptide makes GHK an efficient copper-binding motif.

This is coordination chemistry rather than peptide chemistry. The copper is held by dative bonds from electron-donating atoms on the peptide, forming a defined geometry around the metal centre — not a covalent modification of the peptide in the way an acetyl or PEG group would be.

Why it is blue

The most immediately visible difference between GHK-Cu and an ordinary research peptide is colour. Where a lyophilised peptide is white to off-white, GHK-Cu is distinctly blue.

The colour arises from the copper(II) ion. Cu(II) has an incomplete d-electron shell, and in a coordination environment the d-orbitals split into levels separated by an energy gap that happens to correspond to visible light. Electrons absorbing that energy produce a d-d transition, and the transmitted light gives the characteristic blue.

This is analytically useful. The uncomplexed GHK peptide is colourless; the complex is blue. Visual inspection therefore gives an immediate, if crude, indication that copper is present. More rigorously, ultraviolet-visible spectroscopy of the d-d absorption band provides a quantitative handle on the complex that no ordinary peptide offers.

What verification requires

Because the material is a complex, a purity figure for the peptide component alone is an incomplete specification. Three separate questions need answering, and only the first is a conventional peptide analysis.

• Peptide purity — is the GHK tripeptide itself correct and free of synthesis impurities? Determined by HPLC, typically specified at greater than 98%.
• Copper content — how much copper is present? This is elemental analysis, addressed by atomic absorption spectroscopy or inductively coupled plasma methods, not by peptide chromatography.
• Stoichiometry — is the copper actually complexed at 1:1, or is some fraction present as free copper salt alongside uncomplexed peptide? A physical mixture of GHK and a copper salt could report acceptable figures on the first two tests while not being the complex at all.

The third question is the one most easily overlooked and the one that distinguishes a complete specification from a partial one. Ultraviolet-visible spectroscopy, which probes the metal centre directly, is well suited to it.

Analytical notes on the peptide component

GHK itself is a very short, highly polar tripeptide, and shares the difficulties described for short bioregulator peptides: weak retention on standard reversed-phase columns and limited detection sensitivity, with only two peptide bonds contributing to low-ultraviolet absorbance. The histidine does provide some absorbance, which is more than sequences such as Epitalon offer.

The copper centre also introduces a consideration absent from ordinary peptides: copper(II) is redox-active and can catalyse oxidation reactions. This makes the complex chemically more reactive than the free peptide, and is a reason the material is supplied sealed and dry.

Oxidation state and why it matters

Copper commonly exists in two oxidation states in chemistry: copper(I) and copper(II). These are genuinely different species with different coordination preferences, different geometries and different spectroscopic signatures. GHK-Cu is a copper(II) complex, and that specification is part of the compound’s identity rather than an incidental detail.

The distinction is observable. The visible-region d-d absorption that gives the complex its blue colour is a property of copper(II); copper(I) has a filled d-shell, no d-d transition available, and no colour from that mechanism. A material described as a copper peptide complex that is not blue warrants a question.

Copper(II) is also redox-active, meaning it can participate in electron-transfer chemistry rather than sitting inertly. This makes the complex more chemically reactive than the free peptide and is one reason it is supplied sealed and dry rather than in solution.

Contrast with conventional peptides

It is worth stating plainly how far GHK-Cu sits from the rest of a research peptide catalogue, because the differences shape everything about how it should be documented.

• It is coloured, where lyophilised peptides are white to off-white.
• It contains a metal, so elemental analysis is part of complete characterisation — a technique with no role at all in ordinary peptide verification.
• Its identity depends on a stoichiometric relationship between two components, not on a single covalent structure.
• It offers a visible-region spectroscopic handle that no ordinary peptide provides.
• It is redox-active, where a conventional peptide is chemically inert by comparison.

A specification that treats GHK-Cu as though it were simply a tripeptide addresses only the first of the three verification questions above. That is not a small omission: it leaves both the copper content and the stoichiometry — the features that make the material what it is — entirely unaddressed.

Corix Labs supplies GHK-Cu 50mg and GHK-Cu 100mg as research preparations with batch-level analytical documentation.

Corix Labs publishes analytical documentation for its research materials. See third-party testing reports for further detail on how batches are verified.

All materials referenced in this article are supplied strictly for laboratory research and analytical use. They are not licensed medicines and are not sold for use in humans or animals. Nothing in this article constitutes guidance on administration, preparation for use, or any clinical, therapeutic, diagnostic or cosmetic application.